AzTrials
AzTrials

Osteoarthritis, HipPhase 2NCT00319085

Preheating of Femur Component in Hybrid Total Hip Arthroplasty

A Phase 2 study testing Total hip replacement (Preheating of femur stem) in people with Osteoarthritis, Hip, run by Northern Orthopaedic Division, Denmark at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background Recently published studies confirm that preheating of femoral component enhances shear strength of implant-cement interface. Both Iesaka et al 2003 and Jafri et al 2004 showed reduction in cement porosity on cement-implant interface with preheated femur components. Read more about this study

Who is it for?
Ages 70 to 85 years
Conditions the study is for
Osteoarthritis, Hip
What is being tested?
Total hip replacement (Preheating of femur stem)
Type of treatment
Surgery or procedure
How many people
80 participants
Where
1 siteDenmark
Study dates
May 2006to Apr 2010
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 70 to 85 years
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • The patients suffering of hip osteoarthritis

Who cannot join

  • The patients with ASA score >II
  • The patients with cancer
  • The secondary coxarthrosis after the trauma
  • Any vascular or neuromuscular diseases affecting the hip.

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Farsoe Hospital, Northern Orthopaedic Division

    Farsø, 9640

Other trials in Denmark

About this study

Official title: Comparison Between Preheated and Non-preheated Femur Component in Hybrid Total Hip Arthroplasty (THA) A Prospective Randomized Study of the 80 THA Using Radiostereometry.

Background

  • Recently published studies confirm that preheating of femoral component enhances shear strength of implant-cement interface. Both Iesaka et al 2003 and Jafri et al 2004 showed reduction in cement porosity on cement-implant interface with preheated femur components. We will use the radiostereometry analysis (RSA) to investigate how the preheating of femur component influence on prosthesis survivorship. There are no clinical controlled studies performed to the date.
Read more

The aim of the study

  • Comparison of the migration rates between preheated and non-preheated femur components, analyzed with RSA.

Methods

  • Randomization of 80 patients into 2 groups with 40 in each. All patients will undergo standard hybrid total hip replacement. In group one the femur component (Bi-Metric, Interlock Biomet) will be preheated to 40 degrees of Celsius before cementation. In group two: the control group, the femur component will be of room temperature. We will measure the temperature at cement bone interface during the operation with use of thermocouple electrodes inserted through separate drill hole in the femur. The measurements will be recorded every 10 seconds. The patients will follow the standard postoperative rehabilitation program.
  • The RSA analysis will be performed the first day after the operation and at 3, 12, 24 months postoperatively.
  • The Dual-energy X-ray absorptiometry scanning (DEXA) of the femur will be performed at the first week after the operation and at 12 and 24 months postoperatively.
  • The patients will be followed both clinically and radiologically at 1 and 2 years after the operation (Harris Hip Score).
  • The results will be expressed as mean + SD (in mm). ANOVA statistical analysis will be used to confirm the differences between the groups.
Being tested
Total hip replacement (Preheating of femur stem)
Keywords
Arthroplasty,, Hip,, Pre-heating,, Radiostereometric analysis,, Dual-Energy Radiographic Absorptiometry,
Medical subject headings
Osteoarthritis, Hip

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Total hip replacement (Preheating of femur stem)Procedure or surgery

    Total hybrid hip arthroplasty, cementation of femural component, preheating, radiostereometry, DEXA

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Stem migration in mm

    Measured: 2 years

Secondary outcomes (3)
  1. Bone mineral density g/cm2

    Measured: 2 years

  2. Temperature at bone-cement interface, degrees in Celsius

    Measured: peroperatively

  3. Serum- Titanium measurements in blood samples

    Measured: Not defined

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Apr 2006 (estimated)
  2. Study startMay 2006
  3. Primary completionApr 2010
  4. Study completionApr 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00319085
Sponsor's protocol ID
ON-04-008a-JPE
Status last verified
Apr 2015
First submitted
27 Apr 2006
Last updated
10 Apr 2015
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Total hip replacement (Preheating of femur stem) in people with Osteoarthritis, Hip, run by Northern Orthopaedic Division, Denmark at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Apr 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Stem migration in mm (time frame: 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Apr 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in